Evaluation of Adjunctive Photobiomodulation (PBMT) for COVID-19 Pneumonia via Clinical Status and Pulmonary Severity Indices in a Preliminary Trial

Introduction: The COVID-19 pandemic spread rapidly throughout the world, causing millions of infections, hundreds of thousands of deaths, and overloaded hospitals and intensive care units, with patients in need of critical care management. The purpose of this study is to determine the effectiveness of PBMT on COVID-19 pneumonia.

Conclusion: PBMT is a safe and effective potential treatment for COVID-19 pneumonia and improves clinical status in COVID-19 pneumonia.

No pain. All gain.

Patented and FDA-cleared MLS® Laser Therapy technology provides…

  • Effective treatment of painful and debilitating conditions
  • 85%-90% efficacy rate
  • No risk from surgery or prescription painkillers
  • A cash-based modality to generate revenue for your practice

Learn More about the benefits of MLS Laser Therapy.

Subscribe for Updates

Related Posts